Concepedia

Publication | Open Access

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease

107

Citations

28

References

2020

Year

References

YearCitations

Page 1